Scientists found that GLP-1s like Ozempic may extend human lifespan
- A study found that mice treated with GLP-1 drugs, including Ozempic, lived 12% longer than untreated mice.
- Researchers said, the findings could have implications for human longevity, but further studies are necessary.
- Ozempic, primarily prescribed for diabetes management, has demonstrated potential benefits beyond weight loss & glucose.
- The study underscores ongoing research into GLP-1s as a means to extend lifespan, indicating a new direction for longevity.
Source: vcresearch.berkeley.edu
Get 100 stories a day on the app
Read, watch & listen · Free on iOS & Android
